36 related articles for article (PubMed ID: 19144517)
1. Discovery of novel nucleoside derivatives as selective lysine acetyltransferase p300 inhibitors for cancer therapy.
Dai Q; Yuan Z; Sun Q; Ao Z; He B; Jiang Y
Bioorg Med Chem Lett; 2024 May; 104():129742. PubMed ID: 38604299
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide identification, phylogenetic classification of histone acetyltransferase genes, and their expression analysis in sugar beet (Beta vulgaris L.) under salt stress.
Yolcu S; Skorupa M; Uras ME; Mazur J; Ozyiğit II
Planta; 2024 Mar; 259(4):85. PubMed ID: 38448714
[TBL] [Abstract][Full Text] [Related]
3. First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8.
Fiorentino F; Sementilli S; Menna M; Turrisi F; Tomassi S; Pellegrini FR; Iuzzolino A; D'Acunzo F; Feoli A; Wapenaar H; Taraglio S; Fraschetti C; Del Bufalo D; Sbardella G; Dekker FJ; Paiardini A; Trisciuoglio D; Mai A; Rotili D
J Med Chem; 2023 May; 66(10):6591-6616. PubMed ID: 37155735
[TBL] [Abstract][Full Text] [Related]
4. Cashew Nut Shell Liquid (CNSL) as a Source of Drugs for Alzheimer's Disease.
Uliassi E; de Oliveira AS; de Camargo Nascente L; Romeiro LAS; Bolognesi ML
Molecules; 2021 Sep; 26(18):. PubMed ID: 34576912
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide identification of the histone acetyltransferase gene family in Triticum aestivum.
Gao S; Li L; Han X; Liu T; Jin P; Cai L; Xu M; Zhang T; Zhang F; Chen J; Yang J; Zhong K
BMC Genomics; 2021 Jan; 22(1):49. PubMed ID: 33430760
[TBL] [Abstract][Full Text] [Related]
6. Lysine Acetyltransferase Inhibitors From Natural Sources.
Fiorentino F; Mai A; Rotili D
Front Pharmacol; 2020; 11():1243. PubMed ID: 32903408
[TBL] [Abstract][Full Text] [Related]
7. CuBr-ZnI
Mondal RR; Khamarui S; Maiti DK
ACS Omega; 2016 Aug; 1(2):251-263. PubMed ID: 31457128
[TBL] [Abstract][Full Text] [Related]
8. Protein lysine acetylation by p300/CBP.
Dancy BM; Cole PA
Chem Rev; 2015 Mar; 115(6):2419-52. PubMed ID: 25594381
[No Abstract] [Full Text] [Related]
9. IκB kinase ε targets interferon regulatory factor 1 in activated T lymphocytes.
Sgarbanti M; Marsili G; Remoli AL; Stellacci E; Mai A; Rotili D; Perrotti E; Acchioni C; Orsatti R; Iraci N; Ferrari M; Borsetti A; Hiscott J; Battistini A
Mol Cell Biol; 2014 Mar; 34(6):1054-65. PubMed ID: 24396068
[TBL] [Abstract][Full Text] [Related]
10. Quinoline: A versatile heterocyclic.
Marella A; Tanwar OP; Saha R; Ali MR; Srivastava S; Akhter M; Shaquiquzzaman M; Alam MM
Saudi Pharm J; 2013 Jan; 21(1):1-12. PubMed ID: 23960814
[TBL] [Abstract][Full Text] [Related]
11. Live-cell studies of p300/CBP histone acetyltransferase activity and inhibition.
Dancy BM; Crump NT; Peterson DJ; Mukherjee C; Bowers EM; Ahn YH; Yoshida M; Zhang J; Mahadevan LC; Meyers DJ; Boeke JD; Cole PA
Chembiochem; 2012 Sep; 13(14):2113-21. PubMed ID: 22961914
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic therapeutics in autoimmune disease.
Szyf M
Clin Rev Allergy Immunol; 2010 Aug; 39(1):62-77. PubMed ID: 19644776
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs).
Gorsuch S; Bavetsias V; Rowlands MG; Aherne GW; Workman P; Jarman M; McDonald E
Bioorg Med Chem; 2009 Jan; 17(2):467-74. PubMed ID: 19101154
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of benzamides related to anacardic acid and their histone acetyltransferase (HAT) inhibitory activities.
Souto JA; Conte M; Alvarez R; Nebbioso A; Carafa V; Altucci L; de Lera AR
ChemMedChem; 2008 Sep; 3(9):1435-42. PubMed ID: 18537201
[TBL] [Abstract][Full Text] [Related]
15. Histone acetyl transferases as emerging drug targets.
Dekker FJ; Haisma HJ
Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule inhibitors of histone acetyltransferase activity: identification and biological properties.
Mai A; Rotili D; Tarantino D; Ornaghi P; Tosi F; Vicidomini C; Sbardella G; Nebbioso A; Miceli M; Altucci L; Filetici P
J Med Chem; 2006 Nov; 49(23):6897-907. PubMed ID: 17154519
[TBL] [Abstract][Full Text] [Related]
17. Current development of CBP/p300 inhibitors in the last decade.
He ZX; Wei BF; Zhang X; Gong YP; Ma LY; Zhao W
Eur J Med Chem; 2021 Jan; 209():112861. PubMed ID: 33045661
[TBL] [Abstract][Full Text] [Related]
18. Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases.
Mai A; Rotili D; Tarantino D; Nebbioso A; Castellano S; Sbardella G; Tini M; Altucci L
Bioorg Med Chem Lett; 2009 Feb; 19(4):1132-5. PubMed ID: 19144517
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
